Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Carfilnat 60mg Injection (containing Carfilzomib) is a targeted cancer therapy used in the management of multiple myeloma. It functions as a proteasome inhibitor that blocks the degradation of proteins in cancer cells, leading to cellular stress and apoptosis.
| Strength | 60 mg/vial |
| Formulation | Lyophilized powder (60 mg/vial |
| Storage | 2°C to 8°C |
| Administration | Intravenous (IV) Infusion |
| Drug Class | Proteasome Inhibitor |
| Active Ingredient: | Carfilzomib (60 mg/vial) |